These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9102176)

  • 1. Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension.
    Toft I; Bønaa KH; Ingebretsen OC; Nordøy A; Birkeland KI; Jenssen T
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):553-9. PubMed ID: 9102176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity.
    Mykkänen L; Rönnemaa T; Marniemi J; Haffner SM; Bergman R; Laakso M
    Arterioscler Thromb; 1994 Aug; 14(8):1264-71. PubMed ID: 8049187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.
    De Mitrio V; De Pergola G; Vettor R; Marino R; Sciaraffia M; Pagano C; Scaraggi FA; Di Lorenzo L; Giorgino R
    Metabolism; 1999 Aug; 48(8):960-4. PubMed ID: 10459558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A; Bayraktar M; Kirazli S
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men.
    Byberg L; Siegbahn A; Berglund L; McKeigue P; Reneland R; Lithell H
    Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):258-64. PubMed ID: 9484991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
    Nagi DK; Tracy R; Pratley R
    Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
    van Harmelen V; Wahrenberg H; Eriksson P; Arner P
    Thromb Haemost; 2000 Feb; 83(2):304-8. PubMed ID: 10739390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables.
    Cigolini M; Targher G; Seidell JC; Tonoli M; Schiavon R; Agostino G; De Sandre G
    J Hypertens; 1995 Jun; 13(6):659-66. PubMed ID: 7594424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in hypertension is associated with body fat rather than blood pressure.
    Toft I; Bønaa KH; Jenssen T
    Hypertension; 1998 Jul; 32(1):115-22. PubMed ID: 9674647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women.
    Abbasi F; McLaughlin T; Lamendola C; Lipinska I; Tofler G; Reaven GM
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2818-21. PubMed ID: 10559032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired fibrinolysis and insulin resistance in patients with hypertension.
    Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM
    Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men.
    Cigolini M; Targher G; Seidell JC; Schiavon R; Manara F; Zenti MG; Mattioli C; De Sandre G
    Atherosclerosis; 1994 Apr; 106(2):139-47. PubMed ID: 8060375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents.
    Sudi KM; Gallistl S; Tröbinger M; Payerl D; Weinhandl G; Muntean W; Aigner R; Borkenstein MH
    J Pediatr Endocrinol Metab; 2001 Jan; 14(1):85-94. PubMed ID: 11220710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarction.
    Gray RP; Panahloo A; Mohamed-Ali V; Patterson DL; Yudkin JS
    Atherosclerosis; 1997 Apr; 130(1-2):171-8. PubMed ID: 9126661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction.
    Eržen B; Šabovič M
    Heart Vessels; 2013 Sep; 28(5):570-7. PubMed ID: 23001714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.